Next Article in Journal
Detection of Podocin in Human Urine Sediment Samples by Charge Derivatization and LC-MS-MRM Method
Next Article in Special Issue
Participation of Somatic Stem Cells, Labeled by a Unique Antibody (A3) Recognizing Both N-glycan and Peptide, to Hair Follicle Cycle and Cutaneous Wound Healing in Rats
Previous Article in Journal
Environmental Epigenetics and Genome Flexibility: Focus on 5-Hydroxymethylcytosine
Previous Article in Special Issue
In Vitro Characterization of Adipose Stem Cells Non-Enzymatically Extracted from the Thigh and Abdomen
 
 
Review
Peer-Review Record

Bone Marrow Aspirate Concentrate: Its Uses in Osteoarthritis

Int. J. Mol. Sci. 2020, 21(9), 3224; https://doi.org/10.3390/ijms21093224
by Gi Beom Kim 1, Min-Soo Seo 2, Wook Tae Park 1 and Gun Woo Lee 1,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Int. J. Mol. Sci. 2020, 21(9), 3224; https://doi.org/10.3390/ijms21093224
Submission received: 1 April 2020 / Revised: 30 April 2020 / Accepted: 1 May 2020 / Published: 2 May 2020
(This article belongs to the Special Issue Regenerative Medicine: Role of Stem Cells and Innovative Biomaterials)

Round 1

Reviewer 1 Report

Although this paper is nicely written, this topic has already been published in several other journals. The authors provided some of the research for bone marrow aspirate concentration in the treatment of us arthritis but several clinical studies are missing. In addition some information regarding the constituents of bone marrow are not included in this article. Therefore, do not feel that this manuscript adds to the current literature.

 

I did not feel that this paper adds much to what has ALREADY been published.

Author Response

First of all, we are deeply grateful for your kind and excellent comments on the manuscript.

 

Reviewer 1’s comments: Although this paper is nicely written, this topic has already been published in several other journals. The authors provided some of the research for bone marrow aspirate concentration in the treatment of us arthritis but several clinical studies are missing. In addition, some information regarding the constituents of bone marrow are not included in this article. Therefore, do not feel that this manuscript adds to the current literature.

I did not feel that this paper adds much to what has ALREADY been published.

 

Response: Thank you for your thoughtful review of our article. Unfortunately, we are sorry to disagree with your opinion. As you pointed out, some studies of BMAC have been reported. However, as in this review article, few studies have systematically analyzed the entire contents of BMAC, from the components of BMAC to the latest related technologies. In addition, contrary to your point of view, this study covers various constituents of BMAC, including cellular components, mesenchymal stem cells, growth factors, and cytokine. Although its contents had been already reported, we believe that this review article is worth publishing as an article of IJMS. Please, look forward to considering the positive aspects of our article.

Author Response File: Author Response.doc

Reviewer 2 Report

Reviewer Comments to author

Bone Marrow Aspirate Concentrate: Its Uses in Osteoarthritis

GENERAL COMMENTS

Interesting narrative review

Normal length.

Good english

ABSTRACT

It is concise, and the content is correct
TITLE

The title is correct.

INTRODUCTION

Provide the necessary background for the review

METHODS and MATERIAL

Do not have

RESULTS

Do not have

CONTENT

The manuscript's authors comment on basic science and clinical studies of BMAC and Osteoarthritis

Future trends

CONCLUSION
Do not have

 REFERENCES

Please add the latest studies Gobbi 2018/19

FIGURES

Please add BMAC pictures

Author Response

First of all, we are deeply grateful for your kind and excellent comments on the manuscript.

 

Reviewer 2’s comments:

GENERAL COMMENTS

Interesting narrative review

Normal length.

Good English.

Response: Thank you for your positive comments

 

ABSTRACT

It is concise, and the content is correct.

Response: Thank you for your positive comments

 

TITLE

The title is correct.

Response: Thank you for your positive comments

 

INTRODUCTION

Provide the necessary background for the review

Response: Following your comment, we have added the sentence regarding the necessary background for this review article. Thank you.

Line 45-47: Although several studies on BMAC have been introduced, there has been paucity in the systemically organized review on its overall contents.

 

METHODS and MATERIAL

Do not have

Response: No need to answer.

 

RESULTS

Do not have

Response: No need to answer.

 

CONTENT

The manuscript's authors comment on basic science and clinical studies of BMAC and Osteoarthritis

Future trends

Response: Thank you for your positive comments

 

CONCLUSION

Do not have

Response: No need to answer.

 

REFERENCES

Please add the latest studies Gobbi 2018/19

Response: Following your comment, we have added the recent article of Gobbi et al [Am J Sports Med, 2018]. Moreover, we have added the reference in the section 7 and table 2. As a result, we have also modified the order of the references. Thank you.

Line 221-223: Recently, they reported excellent long-term clinical outcomes of hyaluronic acid-based scaffold embedded with BMAC in a full-thickness cartilage defect [68].

Table 2. Details of the clinical trials of BMAC focusing on cartilage defect.

Authors

Publications

/ Year

Study design

/ No. of patients

Mean age (year)

Mean follow-up period (months)

Defect

/ Location

Treatment

Additional factors

Harvest volume/ kit used

Outcomes

Complications

Gobbi et al. [68]

Am J Sports Med

/ 2019

Case series

/ 23

48.5

96.0

Mean 6.5 cm2 sized ICRS grade IV lesion

/ MFC or patellar or trochlea

BMAC + HA-based scaffold

HTO; TTO; ACLR; LR

60 ml/ SmartPrep2 System

Good to excellent long-term clinical outcomes in full-thickness cartilage injury of the knee joint

N/A

 

FIGURES

Please add BMAC pictures

 

Response: Following your comment, we have added the picture related to BMAC preparation and injection, as a Figure 2, with figure legend (Line 191-193).

Line 221-223: Figure 2. BMAC preparation and knee joint injection. (A) bone marrow aspiration at anterior iliac rim. (B) After centrifugation and some procedure, dark-colored BMAC (white arrow) was obtained. (C) BMAC injection to the knee joint with osteoarthritis.

 

Thank you.

Author Response File: Author Response.doc

Round 2

Reviewer 1 Report

This paper is very well done and complete. It should be very helpful to both scientists and clinicians.

Author Response

Dear reviewer

We are deeply grateful for your excellent comments on our article. We are very honored to be accepted by IJMS. Finally, we have checked the last minor issues of our article for complete acceptance. Two authors were added during the Revision process, we have changed it, and also submitted an authorship change form. Thank you.

 

Sincerely yours,

 

Authors

This manuscript is a resubmission of an earlier submission. The following is a list of the peer review reports and author responses from that submission.


Round 1

Reviewer 1 Report

Although this paper is nicely written, this topic has already been published in several other journals. The authors provided some of the research for bone marrow aspirate concentration in the treatment of us arthritis but several clinical studies are missing. In addition some information regarding the constituents of bone marrow are not included in this article. Therefore, do not feel that this manuscript adds to the current literature.

Reviewer 2 Report

I reviewed the manuscript of Gi Beom Kim and Gun Woo Lee entitled "Bone Marrow Aspirate Concentrate: Its Uses in Osteoarthritis".

The manuscript provides a general overview of the properties of the Bone Marrow Mesenchymal Stem Cells aspirate and its use for the treatment of osteoarthritis.

The manuscript is clear and the topics are well organized through the review. It is well written, and only minor revisions are requested to be suitable for the publication. In particular:

More references should be provided to support some claims:

  • rows 139,140: please add more references describing the immunomodulatory and anti-inflammatory activities of MSC
  • rows 172, 173: please change the current references with more appropriate and significant references (ref [60]- results on 4 patients are not significant; [61] too old for the claim, being published on 2011)
  • In the paragraph "Application modalities", the possibility to perform injections into the subchondral bone should be mentioned, because it has been suggested to be beneficial for the treatment of knee OA because of the current evidence on the role of the subchondral bone in the pathogenesis of the knee OA.

 

Back to TopTop